![Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia - Gibbs - 2020 - Drug and Alcohol Review - Wiley Online Library Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia - Gibbs - 2020 - Drug and Alcohol Review - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/69f302bb-7e97-4d4a-a11e-0df3e65627d7/dar.v39.1.cover.jpg)
Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia - Gibbs - 2020 - Drug and Alcohol Review - Wiley Online Library
![Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study - The Lancet Infectious Diseases Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a00ceeea-af92-4253-b0c5-ed95c5b619d6/gr1_lrg.jpg)
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study - The Lancet Infectious Diseases
![Frontiers | Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier | Neuroscience Frontiers | Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier | Neuroscience](https://www.frontiersin.org/files/Articles/443376/fnins-13-00209-HTML/image_m/fnins-13-00209-g001.jpg)
Frontiers | Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier | Neuroscience
![Innate local response and tissue recovery following application of high density microarray patches to human skin | Scientific Reports Innate local response and tissue recovery following application of high density microarray patches to human skin | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75169-4/MediaObjects/41598_2020_75169_Fig1_HTML.jpg)
Innate local response and tissue recovery following application of high density microarray patches to human skin | Scientific Reports
![Microbiological monitoring during aseptic handling: Methods, limits and interpretation of results - ScienceDirect Microbiological monitoring during aseptic handling: Methods, limits and interpretation of results - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0928098720303286-fx1.jpg)
Microbiological monitoring during aseptic handling: Methods, limits and interpretation of results - ScienceDirect
![Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3d02b2ae-6d49-45ba-bbee-caa4b600f729/gr1.jpg)
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet
![Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/87eb17d4-c29d-4b4c-a636-33c33f4c6600/gr1_lrg.jpg)
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet
Jim Haskins on Twitter: "Friday Night. 28 self administered injections later, I am finally done. Lots of people have to do this daily. Forever. Off the walker and now daily walks on
![Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey - The Lancet Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f206a7c3-c603-48a5-b611-d102224cdf28/gr1_lrg.jpg)